Spirepoint Private Client »

Vertex Pharmaceuticals Incorporated shares owned by Spirepoint Private Client

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Spirepoint Private Client from 13F filings

Historical chart of Spirepoint Private Client investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Spirepoint Private Client consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Spirepoint Private Client

Quarter filed Position value Share count Share price at filing
2025-12-31 $228k 502 453.36

More positions owned by Spirepoint Private Client

United Parcel Service CL B (UPS)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Clean Harbors (CLH)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Select Sector Spdr Tr State Street Tec (XLK)
Alps Etf Tr Alerian Mlp (AMLP)
Select Sector Spdr Tr State Street Uti (XLU)

View all positions for Spirepoint Private Client

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Victory Capital Management
FMR
Jennison Associates
Norges Bank Investment Management

View all funds holding Vertex Pharmaceuticals Incorporated